Applications for San Francisco (Batch 12) extended through September 15th, 2021!

Learn more about investing in Membio

Our team will get back to you soon to follow up on your inquiry.
Membio
We make blood
Founded
2018
Employees*
1-10
Funding to Date*
$23K
Website
membio.ca
Shane Kilpatrick, CEO
The underlying scientific principles that make unprecedented commercial-scale production of red blood cells possible also make the unprecedented commercial-scale production of other whole cell produts possible as well. Membio's biomanufacturing platform has the potential to radically change the entire cell and gene therapy industy!
Every 2 seconds someone in the U.S. needs blood.

Membio is developing a world class biomanufacturing platform to enable the cost-effective and scalable production of whole cells, including red blood cells. Blood is a necessary prerequisite for many life-saving interventions, making a reliable blood supply an essential part of any healthcare system. Membio is on a mission to provide the world with a safe and sustainable supply of blood.

Similar Companies

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.